Lilja Solnes

Medicine & Life Sciences

1. Fluorodeoxyglucose F18 100%
2. 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 95%
3. Prostate-Specific Antigen 94%
4. Prostatic Neoplasms 74%
5. Positron-Emission Tomography 70%
6. Molecular Imaging 61%
7. Single Photon Emission Computed Tomography Computed Tomography 59%
8. Membranes 54%
9. Single-Photon Emission-Computed Tomography 47%
10. Hashimoto's encephalitis 41%
11. Technetium Tc 99m Sestamibi 39%
12. Positron Emission Tomography Computed Tomography 37%
13. Theranostic Nanomedicine 34%
14. Systematic Reviews 32%
15. Neoplasms 32%
16. Meta-Analysis 31%
17. Tomography 31%
18. Therapeutics 29%
19. Thyroid Neoplasms 29%
20. Brain 26%
21. Radiology 26%
22. Brain Neoplasms 24%
23. Anti-N-Methyl-D-Aspartate Receptor Encephalitis 24%
24. ioflupane 23%
25. Neuroendocrine Tumors 22%
26. Neuroimaging 21%
27. Castration 21%
28. Radioisotopes 20%
29. Breast Neoplasms 20%
30. 3-Iodobenzylguanidine 20%
31. Sarcoidosis 19%
32. pertuzumab 19%
33. Paraganglioma 18%
34. Somatostatin 18%
35. Kidney 18%
36. Perfusion 18%
37. Bone and Bones 17%
38. Gastric Emptying 17%
39. Nuclear Medicine 16%
40. Pheochromocytoma 16%
41. Somatostatin Receptors 16%
42. Paraneoplastic Syndromes 16%
43. Peptide Receptors 15%
44. Survival 15%
45. Immunotherapy 15%
46. Radionuclide Imaging 14%
47. Trastuzumab 14%
48. Lung Neoplasms 14%
49. Brown Adipose Tissue 14%